| Date | Form | Description | Docs | XBRL | Pages |
| 03/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 03/10/23 | 8-K | Current report filing |
|
|
24 |
| 01/27/23 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
27 | |
| 01/04/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
40 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...